Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

GW572016 and Trastuzumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER2/Neu
A Phase I, Open-Label Study of the Safety, Tolerability and Pharmacokinetics of GW572016 in Combination With Trastuzumab [Herceptin†]
Status: Enrolling
Updated:  10/1/2015
Jonsson Comprehensive Cancer Center at UCLA
mi
from
Los Angeles, CA
GW572016 and Trastuzumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER2/Neu
A Phase I, Open-Label Study of the Safety, Tolerability and Pharmacokinetics of GW572016 in Combination With Trastuzumab [Herceptin†]
Status: Enrolling
Updated: 10/1/2015
Jonsson Comprehensive Cancer Center at UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast Cancer
Phase I/II Trial of ZD1839 (Iressa®), Trastuzumab (Herceptin®), and Docetaxel (Taxotere®) in Patients With erbB-2 (HER-2) Overexpressing, Stage IV Breast Carcinoma
Status: Enrolling
Updated:  10/1/2015
Tower Cancer Research Foundation
mi
from
Beverly Hills, CA
Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast Cancer
Phase I/II Trial of ZD1839 (Iressa®), Trastuzumab (Herceptin®), and Docetaxel (Taxotere®) in Patients With erbB-2 (HER-2) Overexpressing, Stage IV Breast Carcinoma
Status: Enrolling
Updated: 10/1/2015
Tower Cancer Research Foundation
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast Cancer
Phase I/II Trial of ZD1839 (Iressa®), Trastuzumab (Herceptin®), and Docetaxel (Taxotere®) in Patients With erbB-2 (HER-2) Overexpressing, Stage IV Breast Carcinoma
Status: Enrolling
Updated:  10/1/2015
City of Hope Comprehensive Cancer Center
mi
from
Duarte, CA
Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast Cancer
Phase I/II Trial of ZD1839 (Iressa®), Trastuzumab (Herceptin®), and Docetaxel (Taxotere®) in Patients With erbB-2 (HER-2) Overexpressing, Stage IV Breast Carcinoma
Status: Enrolling
Updated: 10/1/2015
City of Hope Comprehensive Cancer Center
mi
from
Duarte, CA
Click here to add this to my saved trials
Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast Cancer
Phase I/II Trial of ZD1839 (Iressa®), Trastuzumab (Herceptin®), and Docetaxel (Taxotere®) in Patients With erbB-2 (HER-2) Overexpressing, Stage IV Breast Carcinoma
Status: Enrolling
Updated:  10/1/2015
Hematology Oncology Consultants-Hemet
mi
from
Hemet, CA
Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast Cancer
Phase I/II Trial of ZD1839 (Iressa®), Trastuzumab (Herceptin®), and Docetaxel (Taxotere®) in Patients With erbB-2 (HER-2) Overexpressing, Stage IV Breast Carcinoma
Status: Enrolling
Updated: 10/1/2015
Hematology Oncology Consultants-Hemet
mi
from
Hemet, CA
Click here to add this to my saved trials
Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast Cancer
Phase I/II Trial of ZD1839 (Iressa®), Trastuzumab (Herceptin®), and Docetaxel (Taxotere®) in Patients With erbB-2 (HER-2) Overexpressing, Stage IV Breast Carcinoma
Status: Enrolling
Updated:  10/1/2015
Breastlink Medical Group, Incorporated at Long Beach Memorial Medical Center
mi
from
Long Beach, CA
Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast Cancer
Phase I/II Trial of ZD1839 (Iressa®), Trastuzumab (Herceptin®), and Docetaxel (Taxotere®) in Patients With erbB-2 (HER-2) Overexpressing, Stage IV Breast Carcinoma
Status: Enrolling
Updated: 10/1/2015
Breastlink Medical Group, Incorporated at Long Beach Memorial Medical Center
mi
from
Long Beach, CA
Click here to add this to my saved trials
Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast Cancer
Phase I/II Trial of ZD1839 (Iressa®), Trastuzumab (Herceptin®), and Docetaxel (Taxotere®) in Patients With erbB-2 (HER-2) Overexpressing, Stage IV Breast Carcinoma
Status: Enrolling
Updated:  10/1/2015
USC/Norris Comprehensive Cancer Center and Hospital
mi
from
Los Angeles, CA
Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast Cancer
Phase I/II Trial of ZD1839 (Iressa®), Trastuzumab (Herceptin®), and Docetaxel (Taxotere®) in Patients With erbB-2 (HER-2) Overexpressing, Stage IV Breast Carcinoma
Status: Enrolling
Updated: 10/1/2015
USC/Norris Comprehensive Cancer Center and Hospital
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast Cancer
Phase I/II Trial of ZD1839 (Iressa®), Trastuzumab (Herceptin®), and Docetaxel (Taxotere®) in Patients With erbB-2 (HER-2) Overexpressing, Stage IV Breast Carcinoma
Status: Enrolling
Updated:  10/1/2015
City of Hope Medical Group Inc
mi
from
Pasadena, CA
Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast Cancer
Phase I/II Trial of ZD1839 (Iressa®), Trastuzumab (Herceptin®), and Docetaxel (Taxotere®) in Patients With erbB-2 (HER-2) Overexpressing, Stage IV Breast Carcinoma
Status: Enrolling
Updated: 10/1/2015
City of Hope Medical Group Inc
mi
from
Pasadena, CA
Click here to add this to my saved trials
Docetaxel and Erlotinib in Treating Older Patients With Prostate Cancer
Phase II Trial Of TAXOTERE + TARCEVA™ To Treat HRPC In Men ≥ 65 Years Of Age
Status: Enrolling
Updated:  10/1/2015
Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Docetaxel and Erlotinib in Treating Older Patients With Prostate Cancer
Phase II Trial Of TAXOTERE + TARCEVA™ To Treat HRPC In Men ≥ 65 Years Of Age
Status: Enrolling
Updated: 10/1/2015
Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Docetaxel and Erlotinib in Treating Older Patients With Prostate Cancer
Phase II Trial Of TAXOTERE + TARCEVA™ To Treat HRPC In Men ≥ 65 Years Of Age
Status: Enrolling
Updated:  10/1/2015
Jonsson Comprehensive Cancer Center at UCLA
mi
from
Los Angeles, CA
Docetaxel and Erlotinib in Treating Older Patients With Prostate Cancer
Phase II Trial Of TAXOTERE + TARCEVA™ To Treat HRPC In Men ≥ 65 Years Of Age
Status: Enrolling
Updated: 10/1/2015
Jonsson Comprehensive Cancer Center at UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Docetaxel and Erlotinib in Treating Older Patients With Prostate Cancer
Phase II Trial Of TAXOTERE + TARCEVA™ To Treat HRPC In Men ≥ 65 Years Of Age
Status: Enrolling
Updated:  10/1/2015
University Cancer Center at University of Washington Medical Center
mi
from
Seattle, WA
Docetaxel and Erlotinib in Treating Older Patients With Prostate Cancer
Phase II Trial Of TAXOTERE + TARCEVA™ To Treat HRPC In Men ≥ 65 Years Of Age
Status: Enrolling
Updated: 10/1/2015
University Cancer Center at University of Washington Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Warfarin and Vatalanib in Treating Patients With Advanced Solid Tumors
An Open Label, Non Randomized , One Sequence, Add-On Study to Investigate the Effects of PTK787/ZK 222584 on the Pharmacokinetics and Pharmacodynamics of Warfarin at Steady-States in Cancer Patients
Status: Enrolling
Updated:  10/1/2015
Jonsson Comprehensive Cancer Center at UCLA
mi
from
Los Angeles, CA
Warfarin and Vatalanib in Treating Patients With Advanced Solid Tumors
An Open Label, Non Randomized , One Sequence, Add-On Study to Investigate the Effects of PTK787/ZK 222584 on the Pharmacokinetics and Pharmacodynamics of Warfarin at Steady-States in Cancer Patients
Status: Enrolling
Updated: 10/1/2015
Jonsson Comprehensive Cancer Center at UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Aging and Cancer Effects (ACE) Study
Aging and Cancer: The Effects of Comorbidities on Cancer and it's Treatment
Status: Enrolling
Updated:  10/1/2015
University of Wisconsin
mi
from
Madison, WI
Aging and Cancer Effects (ACE) Study
Aging and Cancer: The Effects of Comorbidities on Cancer and it's Treatment
Status: Enrolling
Updated: 10/1/2015
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Acute Side Effects in Patients Who Are Undergoing Stereotactic Radiosurgery for Brain Tumors or Other Brain Disorders
Prospective Study on the Short-Term Adverse Effects From Gamma Knife Radiosurgery
Status: Enrolling
Updated:  10/1/2015
Cleveland Clinic Taussig Cancer Center
mi
from
Cleveland, OH
Acute Side Effects in Patients Who Are Undergoing Stereotactic Radiosurgery for Brain Tumors or Other Brain Disorders
Prospective Study on the Short-Term Adverse Effects From Gamma Knife Radiosurgery
Status: Enrolling
Updated: 10/1/2015
Cleveland Clinic Taussig Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Views on Sharing Family Medical History in Healthy Women Undergoing Mammograms or Breast Evaluation
Patient Perspectives on Sharing Family Medical Histories
Status: Enrolling
Updated:  10/1/2015
Mercy Cancer Center at Mercy Medical Center
mi
from
Canton, OH
Views on Sharing Family Medical History in Healthy Women Undergoing Mammograms or Breast Evaluation
Patient Perspectives on Sharing Family Medical Histories
Status: Enrolling
Updated: 10/1/2015
Mercy Cancer Center at Mercy Medical Center
mi
from
Canton, OH
Click here to add this to my saved trials
Views on Sharing Family Medical History in Healthy Women Undergoing Mammograms or Breast Evaluation
Patient Perspectives on Sharing Family Medical Histories
Status: Enrolling
Updated:  10/1/2015
Geauga Regional Hospital
mi
from
Chardonr, OH
Views on Sharing Family Medical History in Healthy Women Undergoing Mammograms or Breast Evaluation
Patient Perspectives on Sharing Family Medical Histories
Status: Enrolling
Updated: 10/1/2015
Geauga Regional Hospital
mi
from
Chardonr, OH
Click here to add this to my saved trials
Views on Sharing Family Medical History in Healthy Women Undergoing Mammograms or Breast Evaluation
Patient Perspectives on Sharing Family Medical Histories
Status: Enrolling
Updated:  10/1/2015
Lake University Ireland Cancer Center
mi
from
Mentor, OH
Views on Sharing Family Medical History in Healthy Women Undergoing Mammograms or Breast Evaluation
Patient Perspectives on Sharing Family Medical Histories
Status: Enrolling
Updated: 10/1/2015
Lake University Ireland Cancer Center
mi
from
Mentor, OH
Click here to add this to my saved trials
Views on Sharing Family Medical History in Healthy Women Undergoing Mammograms or Breast Evaluation
Patient Perspectives on Sharing Family Medical Histories
Status: Enrolling
Updated:  10/1/2015
Southwest General Health Center
mi
from
Middleburgh Heights, OH
Views on Sharing Family Medical History in Healthy Women Undergoing Mammograms or Breast Evaluation
Patient Perspectives on Sharing Family Medical Histories
Status: Enrolling
Updated: 10/1/2015
Southwest General Health Center
mi
from
Middleburgh Heights, OH
Click here to add this to my saved trials
Views on Sharing Family Medical History in Healthy Women Undergoing Mammograms or Breast Evaluation
Patient Perspectives on Sharing Family Medical Histories
Status: Enrolling
Updated:  10/1/2015
UHHS Chagrin Highlands Medical Center
mi
from
Orange Villager, OH
Views on Sharing Family Medical History in Healthy Women Undergoing Mammograms or Breast Evaluation
Patient Perspectives on Sharing Family Medical Histories
Status: Enrolling
Updated: 10/1/2015
UHHS Chagrin Highlands Medical Center
mi
from
Orange Villager, OH
Click here to add this to my saved trials
Views on Sharing Family Medical History in Healthy Women Undergoing Mammograms or Breast Evaluation
Patient Perspectives on Sharing Family Medical Histories
Status: Enrolling
Updated:  10/1/2015
University Suburban Health Center
mi
from
South Euclid, OH
Views on Sharing Family Medical History in Healthy Women Undergoing Mammograms or Breast Evaluation
Patient Perspectives on Sharing Family Medical Histories
Status: Enrolling
Updated: 10/1/2015
University Suburban Health Center
mi
from
South Euclid, OH
Click here to add this to my saved trials
Views on Sharing Family Medical History in Healthy Women Undergoing Mammograms or Breast Evaluation
Patient Perspectives on Sharing Family Medical Histories
Status: Enrolling
Updated:  10/1/2015
UHHS Westlake Medical Center
mi
from
Westlaker, OH
Views on Sharing Family Medical History in Healthy Women Undergoing Mammograms or Breast Evaluation
Patient Perspectives on Sharing Family Medical Histories
Status: Enrolling
Updated: 10/1/2015
UHHS Westlake Medical Center
mi
from
Westlaker, OH
Click here to add this to my saved trials
A Multiple Ascending Dose Study of R1507 in Children and Adolescents With Advanced Solid Tumors.
Multiple Ascending Dose (MAD) Study of the IGF-1R Antagonist R1507 Administered as an Intravenous Infusion in Pediatric Patients With Advanced Solid Tumors.
Status: Enrolling
Updated:  10/1/2015
Clinical Research Facility
mi
from
Tucson, AZ
A Multiple Ascending Dose Study of R1507 in Children and Adolescents With Advanced Solid Tumors.
Multiple Ascending Dose (MAD) Study of the IGF-1R Antagonist R1507 Administered as an Intravenous Infusion in Pediatric Patients With Advanced Solid Tumors.
Status: Enrolling
Updated: 10/1/2015
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Multiple Ascending Dose Study of R1507 in Children and Adolescents With Advanced Solid Tumors.
Multiple Ascending Dose (MAD) Study of the IGF-1R Antagonist R1507 Administered as an Intravenous Infusion in Pediatric Patients With Advanced Solid Tumors.
Status: Enrolling
Updated:  10/1/2015
Clinical Research Facility
mi
from
Denver, CO
A Multiple Ascending Dose Study of R1507 in Children and Adolescents With Advanced Solid Tumors.
Multiple Ascending Dose (MAD) Study of the IGF-1R Antagonist R1507 Administered as an Intravenous Infusion in Pediatric Patients With Advanced Solid Tumors.
Status: Enrolling
Updated: 10/1/2015
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
A Multiple Ascending Dose Study of R1507 in Children and Adolescents With Advanced Solid Tumors.
Multiple Ascending Dose (MAD) Study of the IGF-1R Antagonist R1507 Administered as an Intravenous Infusion in Pediatric Patients With Advanced Solid Tumors.
Status: Enrolling
Updated:  10/1/2015
Clinical Research Facility
mi
from
Bethesda, MD
A Multiple Ascending Dose Study of R1507 in Children and Adolescents With Advanced Solid Tumors.
Multiple Ascending Dose (MAD) Study of the IGF-1R Antagonist R1507 Administered as an Intravenous Infusion in Pediatric Patients With Advanced Solid Tumors.
Status: Enrolling
Updated: 10/1/2015
Clinical Research Facility
mi
from
Bethesda, MD
Click here to add this to my saved trials
A Multiple Ascending Dose Study of R1507 in Children and Adolescents With Advanced Solid Tumors.
Multiple Ascending Dose (MAD) Study of the IGF-1R Antagonist R1507 Administered as an Intravenous Infusion in Pediatric Patients With Advanced Solid Tumors.
Status: Enrolling
Updated:  10/1/2015
Clinical Research Facility
mi
from
New York, NY
A Multiple Ascending Dose Study of R1507 in Children and Adolescents With Advanced Solid Tumors.
Multiple Ascending Dose (MAD) Study of the IGF-1R Antagonist R1507 Administered as an Intravenous Infusion in Pediatric Patients With Advanced Solid Tumors.
Status: Enrolling
Updated: 10/1/2015
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
A Multiple Ascending Dose Study of R1507 in Children and Adolescents With Advanced Solid Tumors.
Multiple Ascending Dose (MAD) Study of the IGF-1R Antagonist R1507 Administered as an Intravenous Infusion in Pediatric Patients With Advanced Solid Tumors.
Status: Enrolling
Updated:  10/1/2015
Clinical Research Facility
mi
from
Philadelphia, PA
A Multiple Ascending Dose Study of R1507 in Children and Adolescents With Advanced Solid Tumors.
Multiple Ascending Dose (MAD) Study of the IGF-1R Antagonist R1507 Administered as an Intravenous Infusion in Pediatric Patients With Advanced Solid Tumors.
Status: Enrolling
Updated: 10/1/2015
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Multiple Ascending Dose Study of R1507 in Children and Adolescents With Advanced Solid Tumors.
Multiple Ascending Dose (MAD) Study of the IGF-1R Antagonist R1507 Administered as an Intravenous Infusion in Pediatric Patients With Advanced Solid Tumors.
Status: Enrolling
Updated:  10/1/2015
Clinical Research Facility
mi
from
Houston, TX
A Multiple Ascending Dose Study of R1507 in Children and Adolescents With Advanced Solid Tumors.
Multiple Ascending Dose (MAD) Study of the IGF-1R Antagonist R1507 Administered as an Intravenous Infusion in Pediatric Patients With Advanced Solid Tumors.
Status: Enrolling
Updated: 10/1/2015
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Optical Coherence Tomography of the Airway for Lung Cancer or Lung Disease
Optical Coherence Tomography of Human Airways
Status: Enrolling
Updated:  10/1/2015
University Hospitals Seidman Cancer Center
mi
from
Cleveland, OH
Optical Coherence Tomography of the Airway for Lung Cancer or Lung Disease
Optical Coherence Tomography of Human Airways
Status: Enrolling
Updated: 10/1/2015
University Hospitals Seidman Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Compliance to Vaginal Dilation Therapy in Patients Who Have Undergone Radiation Therapy For Stage IB, Stage IIA, Stage IIB, Stage IIIA, or Stage IIIB Cervical Cancer or Stage IA, Stage IB, Stage IIA, or Stage IIB Endometrial Cancer
Adherence to Vaginal Dilation Following Pelvic Radiotherapy for Gynecological Cancers
Status: Enrolling
Updated:  10/1/2015
Geauga Regional Hospital
mi
from
Cleveland, OH
Compliance to Vaginal Dilation Therapy in Patients Who Have Undergone Radiation Therapy For Stage IB, Stage IIA, Stage IIB, Stage IIIA, or Stage IIIB Cervical Cancer or Stage IA, Stage IB, Stage IIA, or Stage IIB Endometrial Cancer
Adherence to Vaginal Dilation Following Pelvic Radiotherapy for Gynecological Cancers
Status: Enrolling
Updated: 10/1/2015
Geauga Regional Hospital
mi
from
Cleveland, OH
Click here to add this to my saved trials
Compliance to Vaginal Dilation Therapy in Patients Who Have Undergone Radiation Therapy For Stage IB, Stage IIA, Stage IIB, Stage IIIA, or Stage IIIB Cervical Cancer or Stage IA, Stage IB, Stage IIA, or Stage IIB Endometrial Cancer
Adherence to Vaginal Dilation Following Pelvic Radiotherapy for Gynecological Cancers
Status: Enrolling
Updated:  10/1/2015
Lake/University Ireland Cancer Center
mi
from
Cleveland, OH
Compliance to Vaginal Dilation Therapy in Patients Who Have Undergone Radiation Therapy For Stage IB, Stage IIA, Stage IIB, Stage IIIA, or Stage IIIB Cervical Cancer or Stage IA, Stage IB, Stage IIA, or Stage IIB Endometrial Cancer
Adherence to Vaginal Dilation Following Pelvic Radiotherapy for Gynecological Cancers
Status: Enrolling
Updated: 10/1/2015
Lake/University Ireland Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Compliance to Vaginal Dilation Therapy in Patients Who Have Undergone Radiation Therapy For Stage IB, Stage IIA, Stage IIB, Stage IIIA, or Stage IIIB Cervical Cancer or Stage IA, Stage IB, Stage IIA, or Stage IIB Endometrial Cancer
Adherence to Vaginal Dilation Following Pelvic Radiotherapy for Gynecological Cancers
Status: Enrolling
Updated:  10/1/2015
Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Compliance to Vaginal Dilation Therapy in Patients Who Have Undergone Radiation Therapy For Stage IB, Stage IIA, Stage IIB, Stage IIIA, or Stage IIIB Cervical Cancer or Stage IA, Stage IB, Stage IIA, or Stage IIB Endometrial Cancer
Adherence to Vaginal Dilation Following Pelvic Radiotherapy for Gynecological Cancers
Status: Enrolling
Updated: 10/1/2015
Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Compliance to Vaginal Dilation Therapy in Patients Who Have Undergone Radiation Therapy For Stage IB, Stage IIA, Stage IIB, Stage IIIA, or Stage IIIB Cervical Cancer or Stage IA, Stage IB, Stage IIA, or Stage IIB Endometrial Cancer
Adherence to Vaginal Dilation Following Pelvic Radiotherapy for Gynecological Cancers
Status: Enrolling
Updated:  10/1/2015
University Suburban Health Center
mi
from
Cleveland, OH
Compliance to Vaginal Dilation Therapy in Patients Who Have Undergone Radiation Therapy For Stage IB, Stage IIA, Stage IIB, Stage IIIA, or Stage IIIB Cervical Cancer or Stage IA, Stage IB, Stage IIA, or Stage IIB Endometrial Cancer
Adherence to Vaginal Dilation Following Pelvic Radiotherapy for Gynecological Cancers
Status: Enrolling
Updated: 10/1/2015
University Suburban Health Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Compliance to Vaginal Dilation Therapy in Patients Who Have Undergone Radiation Therapy For Stage IB, Stage IIA, Stage IIB, Stage IIIA, or Stage IIIB Cervical Cancer or Stage IA, Stage IB, Stage IIA, or Stage IIB Endometrial Cancer
Adherence to Vaginal Dilation Following Pelvic Radiotherapy for Gynecological Cancers
Status: Enrolling
Updated:  10/1/2015
UHHS Chagrin Highlands Medical Center
mi
from
Cleveland, OH
Compliance to Vaginal Dilation Therapy in Patients Who Have Undergone Radiation Therapy For Stage IB, Stage IIA, Stage IIB, Stage IIIA, or Stage IIIB Cervical Cancer or Stage IA, Stage IB, Stage IIA, or Stage IIB Endometrial Cancer
Adherence to Vaginal Dilation Following Pelvic Radiotherapy for Gynecological Cancers
Status: Enrolling
Updated: 10/1/2015
UHHS Chagrin Highlands Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Compliance to Vaginal Dilation Therapy in Patients Who Have Undergone Radiation Therapy For Stage IB, Stage IIA, Stage IIB, Stage IIIA, or Stage IIIB Cervical Cancer or Stage IA, Stage IB, Stage IIA, or Stage IIB Endometrial Cancer
Adherence to Vaginal Dilation Following Pelvic Radiotherapy for Gynecological Cancers
Status: Enrolling
Updated:  10/1/2015
Southwest General Health Center
mi
from
Cleveland, OH
Compliance to Vaginal Dilation Therapy in Patients Who Have Undergone Radiation Therapy For Stage IB, Stage IIA, Stage IIB, Stage IIIA, or Stage IIIB Cervical Cancer or Stage IA, Stage IB, Stage IIA, or Stage IIB Endometrial Cancer
Adherence to Vaginal Dilation Following Pelvic Radiotherapy for Gynecological Cancers
Status: Enrolling
Updated: 10/1/2015
Southwest General Health Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Compliance to Vaginal Dilation Therapy in Patients Who Have Undergone Radiation Therapy For Stage IB, Stage IIA, Stage IIB, Stage IIIA, or Stage IIIB Cervical Cancer or Stage IA, Stage IB, Stage IIA, or Stage IIB Endometrial Cancer
Adherence to Vaginal Dilation Following Pelvic Radiotherapy for Gynecological Cancers
Status: Enrolling
Updated:  10/1/2015
UHHS Westlake Medical Center
mi
from
Cleveland, OH
Compliance to Vaginal Dilation Therapy in Patients Who Have Undergone Radiation Therapy For Stage IB, Stage IIA, Stage IIB, Stage IIIA, or Stage IIIB Cervical Cancer or Stage IA, Stage IB, Stage IIA, or Stage IIB Endometrial Cancer
Adherence to Vaginal Dilation Following Pelvic Radiotherapy for Gynecological Cancers
Status: Enrolling
Updated: 10/1/2015
UHHS Westlake Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Compliance to Vaginal Dilation Therapy in Patients Who Have Undergone Radiation Therapy For Stage IB, Stage IIA, Stage IIB, Stage IIIA, or Stage IIIB Cervical Cancer or Stage IA, Stage IB, Stage IIA, or Stage IIB Endometrial Cancer
Adherence to Vaginal Dilation Following Pelvic Radiotherapy for Gynecological Cancers
Status: Enrolling
Updated:  10/1/2015
Mercy Cancer Center at Mercy Medical Center
mi
from
Cleveland, OH
Compliance to Vaginal Dilation Therapy in Patients Who Have Undergone Radiation Therapy For Stage IB, Stage IIA, Stage IIB, Stage IIIA, or Stage IIIB Cervical Cancer or Stage IA, Stage IB, Stage IIA, or Stage IIB Endometrial Cancer
Adherence to Vaginal Dilation Following Pelvic Radiotherapy for Gynecological Cancers
Status: Enrolling
Updated: 10/1/2015
Mercy Cancer Center at Mercy Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Study of Physical and Mental Health of Older Patients With Newly Diagnosed Cancer
The Geriatric-Oncology Database: A Resource for Advancing Research in Older Cancer Patients
Status: Enrolling
Updated:  10/1/2015
University Hospitals Seidman Cancer Center
mi
from
Cleveland, OH
Study of Physical and Mental Health of Older Patients With Newly Diagnosed Cancer
The Geriatric-Oncology Database: A Resource for Advancing Research in Older Cancer Patients
Status: Enrolling
Updated: 10/1/2015
University Hospitals Seidman Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Study of Physical and Mental Health of Older Patients With Newly Diagnosed Cancer
The Geriatric-Oncology Database: A Resource for Advancing Research in Older Cancer Patients
Status: Enrolling
Updated:  10/1/2015
UHHS Chagrin Highlands Medical Center
mi
from
Cleveland, OH
Study of Physical and Mental Health of Older Patients With Newly Diagnosed Cancer
The Geriatric-Oncology Database: A Resource for Advancing Research in Older Cancer Patients
Status: Enrolling
Updated: 10/1/2015
UHHS Chagrin Highlands Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Lapatinib Resistance in Patients With Breast Cancer
Study of Resistance Mechanisms Against Lapatinib in Patients With ErbB-2-Positive Breast Cancers
Status: Enrolling
Updated:  10/1/2015
Geauga Regional Hospital
mi
from
Cleveland, OH
Lapatinib Resistance in Patients With Breast Cancer
Study of Resistance Mechanisms Against Lapatinib in Patients With ErbB-2-Positive Breast Cancers
Status: Enrolling
Updated: 10/1/2015
Geauga Regional Hospital
mi
from
Cleveland, OH
Click here to add this to my saved trials
Lapatinib Resistance in Patients With Breast Cancer
Study of Resistance Mechanisms Against Lapatinib in Patients With ErbB-2-Positive Breast Cancers
Status: Enrolling
Updated:  10/1/2015
Lake/University Ireland Cancer Center
mi
from
Cleveland, OH
Lapatinib Resistance in Patients With Breast Cancer
Study of Resistance Mechanisms Against Lapatinib in Patients With ErbB-2-Positive Breast Cancers
Status: Enrolling
Updated: 10/1/2015
Lake/University Ireland Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Lapatinib Resistance in Patients With Breast Cancer
Study of Resistance Mechanisms Against Lapatinib in Patients With ErbB-2-Positive Breast Cancers
Status: Enrolling
Updated:  10/1/2015
Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Lapatinib Resistance in Patients With Breast Cancer
Study of Resistance Mechanisms Against Lapatinib in Patients With ErbB-2-Positive Breast Cancers
Status: Enrolling
Updated: 10/1/2015
Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Lapatinib Resistance in Patients With Breast Cancer
Study of Resistance Mechanisms Against Lapatinib in Patients With ErbB-2-Positive Breast Cancers
Status: Enrolling
Updated:  10/1/2015
University Suburban Health Center
mi
from
Cleveland, OH
Lapatinib Resistance in Patients With Breast Cancer
Study of Resistance Mechanisms Against Lapatinib in Patients With ErbB-2-Positive Breast Cancers
Status: Enrolling
Updated: 10/1/2015
University Suburban Health Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Lapatinib Resistance in Patients With Breast Cancer
Study of Resistance Mechanisms Against Lapatinib in Patients With ErbB-2-Positive Breast Cancers
Status: Enrolling
Updated:  10/1/2015
UHHS Chagrin Highlands Medical Center
mi
from
Cleveland, OH
Lapatinib Resistance in Patients With Breast Cancer
Study of Resistance Mechanisms Against Lapatinib in Patients With ErbB-2-Positive Breast Cancers
Status: Enrolling
Updated: 10/1/2015
UHHS Chagrin Highlands Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Lapatinib Resistance in Patients With Breast Cancer
Study of Resistance Mechanisms Against Lapatinib in Patients With ErbB-2-Positive Breast Cancers
Status: Enrolling
Updated:  10/1/2015
Southwest General Health Center
mi
from
Cleveland, OH
Lapatinib Resistance in Patients With Breast Cancer
Study of Resistance Mechanisms Against Lapatinib in Patients With ErbB-2-Positive Breast Cancers
Status: Enrolling
Updated: 10/1/2015
Southwest General Health Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Lapatinib Resistance in Patients With Breast Cancer
Study of Resistance Mechanisms Against Lapatinib in Patients With ErbB-2-Positive Breast Cancers
Status: Enrolling
Updated:  10/1/2015
UHHS Westlake Medical Center
mi
from
Cleveland, OH
Lapatinib Resistance in Patients With Breast Cancer
Study of Resistance Mechanisms Against Lapatinib in Patients With ErbB-2-Positive Breast Cancers
Status: Enrolling
Updated: 10/1/2015
UHHS Westlake Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Lapatinib Resistance in Patients With Breast Cancer
Study of Resistance Mechanisms Against Lapatinib in Patients With ErbB-2-Positive Breast Cancers
Status: Enrolling
Updated:  10/1/2015
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Lapatinib Resistance in Patients With Breast Cancer
Study of Resistance Mechanisms Against Lapatinib in Patients With ErbB-2-Positive Breast Cancers
Status: Enrolling
Updated: 10/1/2015
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Lapatinib Resistance in Patients With Breast Cancer
Study of Resistance Mechanisms Against Lapatinib in Patients With ErbB-2-Positive Breast Cancers
Status: Enrolling
Updated:  10/1/2015
Mercy Cancer Center at Mercy Medical Center
mi
from
Cleveland, OH
Lapatinib Resistance in Patients With Breast Cancer
Study of Resistance Mechanisms Against Lapatinib in Patients With ErbB-2-Positive Breast Cancers
Status: Enrolling
Updated: 10/1/2015
Mercy Cancer Center at Mercy Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Study of Calgranulin A/B Levels in Patients With Newly Diagnosed Stage I,II,III Breast Cancer
A Pilot Trial to Correlate Serum Levels of Calgranulin A and B With Estrogen Receptor Status Among Patients With Breast Cancer
Status: Enrolling
Updated:  10/1/2015
Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Study of Calgranulin A/B Levels in Patients With Newly Diagnosed Stage I,II,III Breast Cancer
A Pilot Trial to Correlate Serum Levels of Calgranulin A and B With Estrogen Receptor Status Among Patients With Breast Cancer
Status: Enrolling
Updated: 10/1/2015
Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Fatigue Caused by Chemotherapy in Women Who Have Undergone Surgery for Breast Cancer and in Healthy Volunteers
Physiology of Chemotherapy Induced Fatigue and Cognitive Dysfunction in Early Stage Breast Cancer
Status: Enrolling
Updated:  10/1/2015
University Hospitals Seidman Cancer Center
mi
from
Cleveland, OH
Fatigue Caused by Chemotherapy in Women Who Have Undergone Surgery for Breast Cancer and in Healthy Volunteers
Physiology of Chemotherapy Induced Fatigue and Cognitive Dysfunction in Early Stage Breast Cancer
Status: Enrolling
Updated: 10/1/2015
University Hospitals Seidman Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Fatigue Caused by Chemotherapy in Women Who Have Undergone Surgery for Breast Cancer and in Healthy Volunteers
Physiology of Chemotherapy Induced Fatigue and Cognitive Dysfunction in Early Stage Breast Cancer
Status: Enrolling
Updated:  10/1/2015
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Fatigue Caused by Chemotherapy in Women Who Have Undergone Surgery for Breast Cancer and in Healthy Volunteers
Physiology of Chemotherapy Induced Fatigue and Cognitive Dysfunction in Early Stage Breast Cancer
Status: Enrolling
Updated: 10/1/2015
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Human Papilloma Virus Infection in HIV-Positive Indian Men Who Have Sex With Men
HPV Infection in Indian HIV-Seropositive Men Who Have Sex With Men (MSM)
Status: Enrolling
Updated:  10/1/2015
UCSF Helen Diller Family Comprehensive Cancer Center
mi
from
San Francisco, CA
Human Papilloma Virus Infection in HIV-Positive Indian Men Who Have Sex With Men
HPV Infection in Indian HIV-Seropositive Men Who Have Sex With Men (MSM)
Status: Enrolling
Updated: 10/1/2015
UCSF Helen Diller Family Comprehensive Cancer Center
mi
from
San Francisco, CA
Click here to add this to my saved trials